Published in Nephrol Dial Transplant on July 01, 2010
Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant (2011) 0.87
Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010. Infect Agent Cancer (2014) 0.79
Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far? Clin Dev Immunol (2013) 0.79
[Transplant-associated lymphoproliferation]. Pathologe (2011) 0.77
A feverish liver transplanted child. Int J Organ Transplant Med (2011) 0.76
Posttransplantation lymphoproliferative disorder after pediatric solid organ transplantation: experiences of 20 years in a single center. Korean J Pediatr (2017) 0.75
Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation. Transplant Res (2016) 0.75
Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation. Oncoimmunology (2016) 0.75
Posttransplant lymphoproliferative disorder presenting as a small bowel obstruction in a patient with pancreas transplantation alone. Proc (Bayl Univ Med Cent) (2014) 0.75
Imaging findings in children with proliferative disorders following multivisceral transplantation. Pediatr Radiol (2015) 0.75
Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients. Pediatr Nephrol (2017) 0.75
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest (2008) 2.73
Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer. Transpl Int (2013) 2.53
Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl (2013) 2.09
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology (2013) 1.93
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol (2006) 1.73
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients. Liver Transpl (2005) 1.52
Budd-Chiari syndrome: current options in interventional radiology treatment exemplified by three selected cases. Med Sci Monit (2005) 1.44
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation (2004) 1.44
Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity. Wideochir Inne Tech Maloinwazyjne (2012) 1.42
Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound. Eur J Gastroenterol Hepatol (2007) 1.42
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
Liver segmentation in living liver transplant donors: comparison of semiautomatic and manual methods. Radiology (2004) 1.39
The place of liver transplantation in Caroli's disease and syndrome. Transpl Int (2006) 1.23
Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs. Nephrol Dial Transplant (2009) 1.18
Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. J Hepatol (2012) 1.14
SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility. J Clin Endocrinol Metab (2013) 1.12
Thrombolytic treatment of portal thrombosis. Hepatogastroenterology (2003) 1.10
Waiting time and transplantation for hepatocellular cancer: a balance between Tempus Fugit and Carpe Diem. Hepatology (2015) 1.08
Inflammation-based scores and hepatocellular carcinoma: "Faithful friends are hard to find". Liver Transpl (2014) 1.07
α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theory. Liver Transpl (2014) 1.04
Congenital intrahepatic bile duct dilatation is a potentially curable disease: long-term results of a multi-institutional study. Ann Surg (2007) 1.03
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg (2007) 1.01
Human alveolar echinococcosis in Poland: 1990-2011. PLoS Negl Trop Dis (2013) 1.01
Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Liver Transpl (2005) 0.99
Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol (2012) 0.98
Urinary levels of interleukin-6 and interleukin-8 in children with urinary tract infections to age 2. Med Sci Monit (2004) 0.96
Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria. Transpl Int (2012) 0.95
Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings. Eur J Gastroenterol Hepatol (2002) 0.94
Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study. Transplantation (2003) 0.94
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation. Pharmacogenet Genomics (2007) 0.92
The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. Ann Transplant (2011) 0.92
Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit (2009) 0.92
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system. Liver Transpl (2011) 0.91
Lack of relationship between interleukin-6 and CRP levels in healthy male athletes. Immunol Lett (2005) 0.90
Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool. Transpl Int (2006) 0.90
Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review. Transpl Int (2010) 0.89
Urine proteome of autosomal dominant polycystic kidney disease patients. Clin Proteomics (2012) 0.89
Impaired glucose metabolism in colorectal cancer. Scand J Gastroenterol (2006) 0.89
Efficacy of rapamycin in patient with juvenile rheumatoid arthritis. Transpl Int (2005) 0.88
Myoid hamartoma of the liver--a novel variant of hamartoma developing in the hilar region and imitating a malignant liver tumor. Med Sci Monit (2004) 0.88
Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance. PLoS One (2013) 0.88
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation (2003) 0.87
High-throughput sequencing identification of novel and conserved miRNAs in the Brassica oleracea leaves. BMC Genomics (2013) 0.87
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience. Transplantation (2013) 0.87
Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int (2011) 0.87
1000 liver transplantations at the Department of General, Transplant and Liver Surgery, Medical University of Warsaw--analysis of indications and results. Pol Przegl Chir (2012) 0.86
Incidence, pattern and clinical relevance of microbial contamination of preservation fluid in liver transplantation. Ann Transplant (2012) 0.86
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl (2010) 0.85
Successful treatment of recurrent cholangitis after adult liver transplantation with a Tsuchida antireflux valve. Transplantation (2004) 0.85
Early post-operative prediction of morbidity and mortality after a major liver resection for colorectal metastases. HPB (Oxford) (2012) 0.85
Infections caused by clostridium difficile in kidney or liver graft recipients. Ann Transplant (2005) 0.85
The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation. Ann Transplant (2003) 0.84
Gene expression profile as a prognostic factor in high-grade gliomas. Int J Oncol (2007) 0.84
Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation (2003) 0.84
Generic formulation of Cyclosporine A, Equoral®, in de novo kidney transplant recipients: five-year follow-up. Ann Transplant (2011) 0.84
A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score. Ann Surg (2016) 0.83
Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007. Transpl Int (2009) 0.83
Castleman's disease - an unusual indication for laparoscopic adrenalectomy. Wideochir Inne Tech Maloinwazyjne (2011) 0.83
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome. Transplantation (2008) 0.83
Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors. Med Sci Monit (2007) 0.83
Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.82
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl (2008) 0.82
Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence. World J Surg (2014) 0.82
Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. Eur J Gastroenterol Hepatol (2010) 0.81
The early and long term function and survival of kidney allografts stored before transplantation by hypothermic pulsatile perfusion. A prospective randomized study. Ann Transplant (2009) 0.81
Stepwise minimization of the immunosuppressive therapy in pediatric liver transplantation. A conceptual approach towards operational tolerance. Acta Gastroenterol Belg (2005) 0.81
Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up. Transpl Int (2005) 0.81
Isolated right posterior bile duct injury following cholecystectomy: report of two cases. World J Gastroenterol (2013) 0.81
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study. Dig Liver Dis (2012) 0.81
Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells. Ther Drug Monit (2009) 0.81
Angiomyolipoma of the liver: analysis of typical features and pitfalls based on own experience and literature. Clin Imaging (2012) 0.81
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update]. Pol Arch Med Wewn (2012) 0.81
Bacteriological urinalysis in patients after renal transplantation. Pol J Microbiol (2005) 0.81
Gall-bladder and hepatoduodenal ligament lymphangioma - case report and literature review. Pol Przegl Chir (2013) 0.81
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report. Liver Int (2007) 0.81
The impact of surgical technique on the results of liver transplantation in patients with hepatocellular carcinoma. Ann Transplant (2013) 0.80
Expression of ghrelin and its receptors in ovarian endometrioma. Gynecol Endocrinol (2011) 0.80
Living Donor Liver Transplantation in Children: Surgical and Immunological Results in 250 Recipients at Université Catholique de Louvain. Ann Surg (2015) 0.80
Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor. Transpl Immunol (2008) 0.80
How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? World J Gastroenterol (2012) 0.80
Proteins contribute insignificantly to the intrinsic buffering capacity of yeast cytoplasm. Biochem Biophys Res Commun (2012) 0.80
Surgical management of congenital intrahepatic bile duct dilatation, Caroli's disease and syndrome: long-term results of the French Association of Surgery Multicenter Study. Ann Surg (2013) 0.80
Detection of active bile leak with Gd-EOB-DTPA enhanced MR cholangiography: comparison of 20-25 min delayed and 60-180 min delayed images. Eur J Radiol (2013) 0.79
Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient. Ann Transplant (2013) 0.79
Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection. Przegl Epidemiol (2013) 0.79